| Literature DB >> 28150446 |
S J Fontaine1, E McCulloch2, P D Eckersall3, H Haining1, J C Patterson Kane, J S Morris1.
Abstract
The modified Glasgow Prognostic Score (mGPS) assigns a numerical value (0-2) from pre-treatment serum concentrations of C-reactive protein (CRP) and albumin to predict patient outcome. CRP and albumin were evaluated in 77 untreated dogs with lymphoma to determine the relationship of mGPS to clinicopathological parameters and whether it could predict progression-free (PFS) and overall survival (OS) in treated dogs. mGPS distribution was significantly associated with clinical stage, substage b, weight loss, gastrointestinal disturbances and lethargy at presentation. On univariate analysis, mGPS was significantly associated with OS and PFS, with shorter median survival times for mGPS 2 compared to mGPS 0 and 1 combined. Hypoalbuminaemia significantly reduced OS and PFS, however increased CRP had no effect. Only clinical stage was significantly associated with OS and PFS on both univariate and multivariate analysis. mGPS has potential prognostic value for canine lymphoma , but further studies are needed.Entities:
Keywords: C-reactive protein; albumin; biomarker; canine; lymphosarcoma; survival time
Mesh：
Substances：
Year: 2017 PMID： 28150446 DOI： 10.1111/vco.12296
Source DB: PubMed Journal: Vet Comp Oncol ISSN： 1476-5810 Impact factor: 2.613